This clinical overview details the latest evidence-based strategies for diagnosing and treating symptoms of benign prostatic hyperplasia in men.

The Trump administration on Tuesday announced the next round of prescription drugs up for Medicare price negotiations.

CMS's third drug negotiation cycle under the IRA targets high-expenditure drugs, impacting Medicare Part B and D spending. The list includes drugs for cancer, HIV, and diabetes, with significant ...

As US medtech heavyweights pour billions into bladder-control therapies for ageing populations, an Australian company is ...

CMS has announced that the new cycle of drug price negotiations by Medicare will include big-name drugs for diabetes and HIV/AIDS, as well as Botox injections. 1,2 The 15 high-cost prescription drugs ...

Retreatment after benign prostatic hyperplasia (BPH) procedures appear lowest for men undergoing simple prostatectomy, HoLEP, ...

Medicare will negotiate prices for Part B injectable drugs for the first time, aiming to lower costs for millions of patients ...

List includes medications for diabetes, cancer, arthritis, and more ...

Tuesday's announcement is part of the Trump administration's efforts to reduce prescription drug costs for Americans, with ...